The Addition of Concurrent Immune Checkpoint Inhibitors for Chemoradiotherapy With Consolidative Immune Checkpoint Inhibitors in Unresectable Cancers: A Systematic Review and Meta‐Analysis

Documenti analoghi

• Targeting HIF as a Promising Approach to Synergize With Immune Checkpoint Inhibitors
  di: Shuai Li, et al.
  Pubblicazione: (2026)
• Current Advances and Future Directions for Sensitizing Gastric Cancer to Immune Checkpoint Inhibitors
  di: Wenke Li, et al.
  Pubblicazione: (2025)
• Efficacy and Safety of Immune Checkpoint Inhibitors in the Treatment of Hematologic Malignancies: An Umbrella Review of Systematic Reviews and Meta‐Analyses
  di: Zhengyu Yu, et al.
  Pubblicazione: (2026)
• Immune Checkpoint Inhibitors +/− Chemotherapy for Patients With NSCLC and Brain Metastases: A Systematic Review and Network Meta‐Analysis
  di: Lauren Julia Brown, et al.
  Pubblicazione: (2025)
• Prognostic Potential of Baseline Eosinophils at the Initiation of Immune Checkpoint Inhibitor Treatment of Metastatic Melanoma: A Systematic Review and Meta‐Analysis
  di: Thilo Gambichler, et al.
  Pubblicazione: (2025)